A new 1,2,3-triazole-indirubin hybrid suppresses tumor growth and pulmonary metastasis by mitigating the HGF/c-MET axis in hepatocellular carcinoma | Synapse
March 3, 2026
A new 1,2,3-triazole-indirubin hybrid suppresses tumor growth and pulmonary metastasis by mitigating the HGF/c-MET axis in hepatocellular carcinoma
Key Points
Tumor growth suppression is observed, indicating effectiveness in treatment.
The hybrid compound targets the HGF/c-MET signaling pathway, reducing metastasis rates.
Assessment using the hybrid compound demonstrates promise in preventing aggressive cancer spread.
This highlights the potential of new therapeutic strategies in managing hepatocellular carcinoma.